Consensus Al-Dawaa Medical Services Company

Actions

4163

SA15H14I11H6

Pharmacies

Marché Fermé - 09:20:57 01/11/2026 Varia. 5j. Varia. 1 janv.
36,26 SAR -1,68% Graphique intraday de Al-Dawaa Medical Services Company +2,14% -27,33%

Evolution de l'Objectif Moyen: Al-Dawaa Medical Services Company

Evolution de l'Objectif Moyen - Al-Dawaa Medical Services Company

Evolution de l'Objectif de Cours: Al-Dawaa Medical Services Company

Evolution de l'Objectif de Cours - Al-Dawaa Medical Services Company

Changements de Recommandations des Analystes: Al-Dawaa Medical Services Company

43c4b84dfa9c.y5snTM6GuWXD1qJ9X6eLlK9JqH6YzmtaJYxcyC4qti8.k81oKIH87QuvjNMeN8O95p0g-Rb5-V4wEc4_q1RD032Bw2N8_-TxHYHgmg~f976acf42db73e10f2adc8fe5ab423cb
12/10 Al-Dawaa Medical Services Company : EFG-Hermes Brokerage confirme sa recommandation neutre ZM
03/09 Al-Dawaa Medical Services Company : Kepler Cheuvreux toujours neutre sur le dossier ZM
02/09 Al-Dawaa Medical Services Company : Morgan Stanley toujours neutre sur le dossier ZM
18/08 Al-Dawaa Medical Services Company : JPMorgan désormais pessimiste ZM
14/08 Al-Dawaa Medical Services Company : Citigroup maintient sa recommandation neutre ZM
12/08 Al-Dawaa Medical Services Company : Riyad Capital est neutre sur le titre ZM
12/08 Riyad Capital ajuste l'objectif de cours d'Al-Dawaa Medical Services après les résultats du deuxième trimestre MT
04/08 Al-Dawaa Medical Services Company : ANB Capital conserve son opinion neutre ZM
15/07 Al-Dawaa Medical Services Company : JPMorgan conserve son opinion neutre ZM
10/07 Al-Dawaa Medical Services Company : Morgan Stanley toujours neutre sur le dossier ZM
12/06 Al-Dawaa Medical Services Company : Riyad Capital conserve son opinion neutre ZM
04/06 Al-Dawaa Medical Services Company : Morgan Stanley n'est pas inspiré par le dossier ZM
02/06 Al-Dawaa Medical Services Company : Citigroup confirme sa recommandation neutre ZM
08/05 Al-Dawaa Medical Services Company : Riyad Capital moins optimiste ZM
28/04 Al-Dawaa Medical Services Company : Morgan Stanley abaisse son opinion à neutre ZM
02/02 Al-Dawaa Medical Services Company : Morgan Stanley toujours à l'achat ZM
24/11 Al-Dawaa Medical Services Company : Citigroup conserve son opinion neutre ZM
01/10/25 Al-Dawaa Medical Services Company : Citigroup de acheteur à neutre sur le titre ZM
29/09/25 Al-Dawaa Medical Services Company : EFG-Hermes Brokerage de acheteur à neutre sur le titre ZM
09/09/25 Al-Dawaa Medical Services Company : ANB Capital moins optimiste ZM
26/08/25 Al-Dawaa Medical Services Company : JPMorgan passe à neutre sur le dossier ZM
03/06/25 Al-Dawaa Medical Services Company : EFG-Hermes Brokerage favorable sur le dossier ZM
28/11/24 Al-Dawaa Medical Services Company : Citigroup favorable sur le dossier ZM
23/08/24 Al-Dawaa Medical Services Company : SNB Capital reste à l'achat ZM
23/08/24 Al-Dawaa Medical Services Company : SNB Capital favorable sur le dossier ZM

Consensus Évolution recommandations analystes 4 mois Divergence estimations Divergence objectif analystes Ecart obj. / dr
- +19,51%
+80,44%
+16,13%
+16,88%
+57,16%
+69,29%
+20,86%
+18,4%
+26,66%
+22,01%
Moyenne +34,73%
Moyenne pondérée par Capi. +45,21%


Consensus des Analystes

Vente
Consensus
Achat
Recommandation moyenne
CONSERVER
Nombre d'Analystes
8
Dernier Cours de Cloture
36,88SAR
Objectif de cours Moyen
44,08SAR
Ecart / Objectif Moyen
+19,51%
Objectif de cours Haut
62,20SAR
Ecart / Objectif Haut
+68,66%
Objectif de cours Bas
34,00SAR
Ecart / Objectif Bas
-7,81%

Détail du Consensus des Analystes

Consensus des analystes - Al-Dawaa Medical Services Company

Evolution du consensus

Evolution du consensus - Al-Dawaa Medical Services Company
Trader
Investisseur
Globale
Qualité
ESG MSCI
B
Ratings Zonebourse - Al-Dawaa Medical Services Company
  1. Bourse
  2. Actions
  3. Action 4163
  4. Consensus Al-Dawaa Medical Services Company